Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related-Reference-Cited by-同舟云学术

Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related

Published:2008-09 Issue:6 Volume:13 Page:799-809
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:

Author:

REID David W.,WEN Yudong,JOHNS David P.,WILLIAMS Trevor J.,WARD Chris,WALTERS E. Haydn

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1843.2008.01380.x/fullpdf

Reference38 articles.

1. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease;Reid;Intern. Med. J.,2003

2. Steroid response in stable chronic obstructive pulmonary disease;Mendella;Ann. Intern. Med.,1982

3. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group;Kerstjens;Eur. Respir. J.,1993

4. Corticosteroid reversibility in COPD is related to features of asthma;Chanez;Am. J. Respir. Crit. Care Med.,1997

5. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema;Fujimoto;Chest,1999

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How inhaled corticosteroids target inflammation in COPD;European Respiratory Review;2023-10-18

2. Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2023-03-27

3. Clinical Assessment and Utility of Biomarkers in Asthma-Chronic Obstructive Pulmonary Disease Overlap;Immunology and Allergy Clinics of North America;2022-08

4. Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care;European Respiratory Review;2021-06-01

5. Eosinophils in COPD—Current Concepts and Clinical Implications;The Journal of Allergy and Clinical Immunology: In Practice;2020-09